Retracted Article: Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4

Pengwei Lu, Xue Yang, Yunqing Yang, Fang Wang, Lin Li, Yuanting Gu

Open source

DOI
10.1039/c8ra00296g
Published
2018
Container
RSC Advances
Publisher
Royal Society of Chemistry (RSC)
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1039/c8ra00296g,
  title = {Retracted Article: Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4},
  author = {Pengwei Lu and Xue Yang and Yunqing Yang and Fang Wang and Lin Li and Yuanting Gu},
  year = {2018},
  journal = {RSC Advances},
  doi = {10.1039/c8ra00296g},
  url = {https://doi.org/10.1039/c8ra00296g}
}

RIS

TY  - JOUR
TI  - Retracted Article: Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4
AU  - Pengwei Lu
AU  - Xue Yang
AU  - Yunqing Yang
AU  - Fang Wang
AU  - Lin Li
AU  - Yuanting Gu
PY  - 2018
JO  - RSC Advances
DO  - 10.1039/c8ra00296g
UR  - https://doi.org/10.1039/c8ra00296g
ER  - 

APA

Lu, P., Yang, X., Yang, Y., Wang, F., Li, L., & Gu, Y. (2018). Retracted Article: Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4. RSC Advances. https://doi.org/10.1039/c8ra00296g

Source records